Skip to main content
Diyavarshini Gopaul on Muck Rack

Diyavarshini Gopaul

As seen in: BioRxiv, The Journal of Clinical Investigation
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Diyavarshini

Contact Diyavarshini, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Quantitative functional profiling of ERCC2 mutations deciphers cisplatin sensitivity in bladder cancer

|
By Judit Börcsök, Diyavarshini Gopaul, Daphne Devesa-Serrano, Clémence Mooser
| The Journal of Clinical Investigation
Abstract Tumor gene alterations can serve as predictive biomarkers for therapy response. The nucleotide excision repair (NER) helicase ERCC2 carries heterozygous missense mutations in approximately 10% of bladder tumors, and these may predict sensitivity to cisplatin treatment.
Open in Who Shared Issue with article?

Regulation of oncogene-induced senescence by the MRE11 and TREX1 nucleases

|
By Yea-Lih Lin, Herve Techer, Diyavarshini Gopaul, Jonathan Heuze
| BioRxiv
Thank you for your interest in spreading the word about bioRxiv. NOTE: Your email address is requested solely to identify you as the sender of this article. Your Email * Your Name * Send To * Enter multiple addresses on separate lines or separate them with commas. Message Subject (Your Name) has forwarded a page to you from bioRxiv Message Body (Your Name) thought you would like to see this page from the bioRxiv website.
Open in Who Shared View Duplicates (696) Issue with article?
See all 2 articles